Five University of South Florida (USF) Professors received 2018 Excellence in Innovation Awards from the university’s chapter of the National Academy of Inventors in September. USF Research News states that the faculty were recognized for inventing and patenting new technology, creating startup companies and securing research grants and outside investment funding as well as supporting student innovators in research projects.Read More
Science Market Update
Tags: bioengineering, biomedical researh, USF, University of South Florida, USF Health Morsani College of Medicine, Biomedical Engineering, Biotech Event, Biotechnology trade show, Biotechnology Vendor Fair, virus research, April 2019, cancer research, Cancer Treatment, breast cancer research, breast cancer funding, colon cancer, biofuel research
The National Cancer Institute awards the University of Illinois at Urbana-Champaign roughly $5 million in research funding each year. This funding supports a number of cancer research projects conducted at the university. One such project is a ground breaking study of nanoparticles that researchers designed to specifically bind to a protein that marks the surface of breast cancer stem cells and destroy them. These elusive and rare cells can cause cancer to come back years after the tumor has been treated.Read More
Tags: UIUC, UI Urbana, University of Illinois Urbana-Champaign, breast cancer research, cancer therapy, Midwest Region, cancer research, Cancer Treatment, Cancer, lab suppliers, BioResearch Product Faire, Laboratory Equipment Supplier, life science researchers
According to the American Cancer Society, 1 in 8 American women will develop invasive breast cancer in their lifetime, and each year over 40,000 women die from it. However, thanks to research conducted at the University of Illinois Urbana-Champaign, the number of deaths due to breast cancer may soon be significantly reduced.Read More
According to the American Cancer Society, nearly 1 in 8 women will develop breast cancer in their lives, making it the second most common cancer for American women. However, breast cancer does not affect all women equally. Past studies have shown that women of African descent with breast cancer die at a higher rate than white women. Researchers at the University of Southern California Keck School of Medicine have received a grant of $12 million from the National Cancer Institute (NCI) to study the disparities in breast cancer in women.Read More
Scientists at Harvard Medical have made a recent breakthrough in cancer therapy research with the help of three separate grants from the National Institutes of Health, totaling over $1,153,000.Read More
Tags: Harvard University, breast cancer research, cancer research, Massachusetts, Longwood Medical Center, 2015, Boston, BioResearch Product Faire Event, Harvard Medical, MA, Harvard, NIH funding, research grants, breast cancer funding, NIH grants, cancer research funding, best lab supply tradeshows, best science tradeshows
Mayo Clinic researchers have compiled a set of common genetic variants that they say contribute to a person’s risk for developing breast cancer.Read More
USC researchers Heinz-Josef Lenz and Min Yu are hoping to put a stop to cancer…literally. Though differing in methodology and the specific foci of their research, both Lenz and Yu are working towards halting cancer proliferation via their groundbreaking research at USC.Read More
Researchers and fundraisers alike are passionate about finding innovative, new and more effective treatments for breast cancer in women. Breast cancer forms in the tissue of the breast, and the most common form is ductal carcinoma, which begins in the lining of the milk ducts. In 2014, 232,670 women were diagnosed with breast cancer, while the death rate for 2014 was 40,000 women.
A laboratory testing kit developed at the University of North Carolina Lineberger Comprehensive Cancer Center received approval from the U.S. Food and Drug Administration. Developed by Chuck Perou, PhD and professor of genetics and pathology, the testing kit estimates the risk of breast cancer relapse even in cases of anti-hormone treatment. According to the University of North Carolina at Chapel Hill, other scientists who worked with Perou include Dr. Joel Parker and Dr. Maggie Cheang at the University of North Carolina.